- Home
- MSGE vs ARQT Comparison
MSGE vs ARQT Comparison
Compare MSGE & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSGE
- ARQT
- Stock Information
- Founded
- MSGE 2020
- ARQT 2016
- Country
- MSGE United States
- ARQT United States
- Employees
- MSGE N/A
- ARQT N/A
- Industry
- MSGE Services-Misc. Amusement & Recreation
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- MSGE Consumer Discretionary
- ARQT Health Care
- Exchange
- MSGE Nasdaq
- ARQT Nasdaq
- Market Cap
- MSGE 1.9B
- ARQT 1.7B
- IPO Year
- MSGE N/A
- ARQT 2020
- Fundamental
- Price
- MSGE $39.25
- ARQT $15.69
- Analyst Decision
- MSGE Strong Buy
- ARQT Strong Buy
- Analyst Count
- MSGE 5
- ARQT 7
- Target Price
- MSGE $50.20
- ARQT $19.00
- AVG Volume (30 Days)
- MSGE 328.8K
- ARQT 1.8M
- Earning Date
- MSGE 08-13-2025
- ARQT 08-06-2025
- Dividend Yield
- MSGE N/A
- ARQT N/A
- EPS Growth
- MSGE N/A
- ARQT N/A
- EPS
- MSGE 0.77
- ARQT N/A
- Revenue
- MSGE $942,734,000.00
- ARQT $263,464,999.00
- Revenue This Year
- MSGE $8.62
- ARQT $61.83
- Revenue Next Year
- MSGE $4.69
- ARQT $36.55
- P/E Ratio
- MSGE $50.64
- ARQT N/A
- Revenue Growth
- MSGE N/A
- ARQT 99.50
- 52 Week Low
- MSGE $28.29
- ARQT $8.03
- 52 Week High
- MSGE $44.14
- ARQT $17.75
- Technical
- Relative Strength Index (RSI)
- MSGE 55.50
- ARQT 53.84
- Support Level
- MSGE $36.67
- ARQT $13.70
- Resistance Level
- MSGE $37.73
- ARQT $16.27
- Average True Range (ATR)
- MSGE 1.24
- ARQT 0.94
- MACD
- MSGE 0.17
- ARQT 0.03
- Stochastic Oscillator
- MSGE 75.92
- ARQT 55.49
About MSGE Madison Square Garden Entertainment Corp.
Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.